NANOVA INC.

Medtech · Private

Plasma-coated coronary stents with improved biocompatibility using low-temperature plasma deposition of nano-scale coating layers

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$6.1M
Federal grants
$6.1M
5 awards · 2017–2019
Rank in peer group#335 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
7 pending · first 2017
Rank in peer group#158 of 538

Capital timeline

201720182019FEDERAL ↑EQUITY ↓Cumulative $6.1M$938K$3M$42K$1.1M$1M
201720182019FEDERAL ↑EQUITY ↓Cumulative $6.1M$938K$3M$1.1M$1M

Latest events

  • Federal grantHealth and Human S · Phase II · Improved long-term biocompatibility of coronary stents by plasma coating process$1M
  • Federal grantHealth and Human S · Phase II · Improved long-term biocompatibility of coronary stents by plasma coating process$1.1M
  • Federal grantHealth and Human S · Phase II · Improved long-term biocompatibility of coronary stents by plasma coating process$42K
  • Federal grantHealth and Human S · Phase II · Improved long-term biocompatibility of coronary stents by plasma coating process$3M
  • Federal grantHealth and Human S · Phase II · Improved long-term biocompatibility of coronary stents by plasma coating process$938K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#158 · top 29%
  • Linked publications#2 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 10
Show all 10 patent records
  • Device For Generating And Delivering Low Temperature PlasmaApr 21, 2020 · US 10,631,396Granted
  • Methods And Compositions For Treating Bacterial InfectionOct 15, 2019 · US 10,441,588Granted
  • Atmospheric Non-thermal Gas Plasma Method For Dental Surface TreatmentSep 26, 2019 · Application 16379143Pending
  • Compounds And Methods For Treatment Of Cystic FibrosisJul 11, 2019 · Application 16240679Pending
  • Methods And Compositions For Treating Bacterial InfectionNov 14, 2017 · US 9,814,719Granted
  • Low Temperature Plasma Coating For Anti-biofilm FormationJul 18, 2013 · Application 13741216Pending
  • Compounds And Methods For Treatment Of Cystic FibrosisApplication 62613962Pending
  • Device For Generating And Delivering Low Temperature PlasmaApplication 62473961Pending
  • Device For Generating And Delivering Low Temperature PlasmaApplication PCTUS2018023142Pending
  • Compounds And Methods For Treatment Of Cystic FibrosisApplication PCTUS2019012433Pending

Recent research by its founders

  • Evolution and distribution of thermal stress during the shouldering stage of Czochralski silicon growth: Effects on defect dynamics and strategies for process optimization20260 cites
  • Structural modulation of BiOCl through basic bismuth nitrate/polyacrylic acid mediation and post-treatment for visible-light photocatalysis20260 cites
  • Dynamic keystroke-password recognition based on piezoelectric-triboelectric coupling sensor array with crosstalk-free for authentication system202521 cites

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .